NDC 0173-0887 – Trelegy Ellipta
Fluticasone Furoate 100 ug/1; Umeclidinium Bromide 62.5 ug/1; Vilanterol Trifenatate 25 ug/1 · Powder · Respiratory (inhalation)
Product NDC0173-0887
Product details
- Brand name
- Trelegy Ellipta
- Generic name
- Fluticasone furoate, umeclidinium bromide and vilanterol trifenatate
- Labeler
- GlaxoSmithKline LLC
- Dosage form
- Powder
- Route
- Respiratory (inhalation)
- Marketing category
- NDA · NDA209482
- Marketed since
- September 18, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Anticholinergic; Corticosteroid; beta2-Adrenergic Agonist
Active ingredients
- Fluticasone Furoate 100 ug/1
- Umeclidinium Bromide 62.5 ug/1
- Vilanterol Trifenatate 25 ug/1
Uses, dosage, side effects and warnings for Trelegy Ellipta →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 0173-0887-10 | 1 TRAY in 1 CARTON (0173-0887-10) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER | Sep 18, 2017 |
| 0173-0887-14 | 1 TRAY in 1 CARTON (0173-0887-14) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER | Sep 18, 2017 |
| 0173-0887-61 sample | 1 TRAY in 1 CARTON (0173-0887-61) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER | Sep 18, 2017 |
Recalls mentioning this NDC
- D-0482-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage. - D-0481-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Other Trelegy Ellipta products
- 0173-0893 Fluticasone Furoate 200 ug/1; Umeclidinium Bromide 62.5 ug/1;… · Powder · GlaxoSmithKline LLC